Bcl-2, Bcl-x, and Bax Expression by Immunohistochemistry in Inclusion Body Myositis

2001 ◽  
Vol 125 (10) ◽  
pp. 1326-1330
Author(s):  
Richard A. Prayson ◽  
Albert C. Yu

Abstract Context.—Bcl-2, Bcl-x, and Bax are among the variety of proteins that have been described as being involved in the regulation of apoptotic cell death. Bcl-2 and Bcl-xL inhibit apoptosis, and Bax is proapoptotic. Objective.—To evaluate the expression of Bcl-2, Bcl-x, and Bax in inclusion body myositis (IBM). Design.—We examined muscle specimens from 27 patients (17 men, 10 women) with IBM to evaluate Bcl-2, Bcl-x, and Bax expression by immunohistochemistry. Results.—Patient ages ranged from 29 to 80 years (mean 62.2 years). All biopsies were marked by endomysial chronic inflammation, muscle fiber necrosis, and regeneration. Rimmed (autophagic) vacuoles were present in all cases. Ragged red fibers were noted in 4 biopsies (15%), and cytochrome oxidase–deficient fibers were found in 10 biopsies (37%). Ultrastructural evidence of intranuclear or cytoplasmic tubulofilamentous inclusions, confirming the diagnosis of IBM, were noted in all cases. Paracrystalline mitochondrial inclusions were seen in 5 biopsies (18.5%). Inflammatory cells stained positively with Bcl-2 in all biopsies, Bax in 26 biopsies (96%), and Bcl-x in 8 biopsies (30%). Degenerating muscle fibers were highlighted with Bax in 24 biopsies (89%), Bcl-2 in 2 biopsies (7%), and Bcl-x in 3 biopsies (11%). Regenerative muscle fibers were noted to stain with Bax in 24 muscles (89%), Bcl-2 in 21 muscles (78%), and Bcl-x in 4 muscles (15%). Rimmed vacuoles were highlighted by Bax in 24 biopsies (89%) and only rarely by Bcl-2 (n = 2, 7%) and Bcl-x (n = 3, 11%). A subsarcolemmal staining pattern was observed in 21 biopsies (78%) with Bax, 6 biopsies (22%) with Bcl-2, and only 1 biopsy (4%) with Bcl-x. Conclusions.—(1) Bax (proapoptotic) immunostaining highlighted most autophagic vacuoles; (2) subsarcolemmal Bax and Bcl-2 immunoreactivity may be associated with mitochondrial defects that are commonly noted in IBM; (3) Bcl-2 and Bax immunoreactivity were not confined to degenerating muscle fibers and in fact appeared to be expressed more commonly in regenerating fibers, suggesting that their expression may be independent of apoptosis in the setting of IBM.

2011 ◽  
Vol 503 (3) ◽  
pp. 229-233 ◽  
Author(s):  
Anna Nogalska ◽  
Carla D’Agostino ◽  
W. King Engel ◽  
Valerie Askanas

2021 ◽  
Vol 14 (2) ◽  
pp. e238312
Author(s):  
Christina Law ◽  
Huili Li ◽  
Sankar Bandyopadhyay

While sporadic inclusion body myositis (sIBM) is the most commonly acquired inflammatory myopathy above 50 years of age, its refractory response to conventional immunosuppressive treatments raises questions about its perplexing pathogenesis. Muscle biopsy typically reveals major histocompatibility complex I antigens and CD8+ T cell endomysial infiltrates invading non-necrotic muscle fibres early in the disease course with rimmed vacuoles, protein aggregates and amyloid inclusions later in the disease. Transactive response DNA-binding protein-43 (TDP-43), a protein implicated in transcriptional repression in neurodegenerative diseases, is also found in sIBM. C5b-9 membrane attack complex, an effector protein involved in the complement cascade of the immune response, is commonly found in dermatomyositis, but has rarely been reported in IBM. We describe a novel case of IBM with simultaneous C5b-9 and TDP-43 staining on quadriceps biopsy, raising the question of a possibility of concurrent immune-mediated inflammatory and myodegenerative pathogenesis.


2010 ◽  
Vol 120 (5) ◽  
pp. 661-666 ◽  
Author(s):  
Anna Nogalska ◽  
Carla D’Agostino ◽  
W. King Engel ◽  
William L. Klein ◽  
Valerie Askanas

2011 ◽  
Vol 122 (5) ◽  
pp. 627-636 ◽  
Author(s):  
Carla D’Agostino ◽  
Anna Nogalska ◽  
Mafalda Cacciottolo ◽  
W. King Engel ◽  
Valerie Askanas

2019 ◽  
Vol 17 (2) ◽  
pp. 193-195
Author(s):  
Marco Orsini ◽  
Mariana Pimentel Mello ◽  
Marcos RG de Freitas ◽  
Osvaldo JM Nascimento

Familial inclusion body myositis (FIBM) is extremely rare. The disease is characterized by relatively late onset, selective and early involvement of quadriceps, forearm and finger flexors, only mild increase of serum creatine kinase CK level, frequent rimmed vacuoles in muscle histopathology with substantial inflammatory cell infiltration. The combination of clinical, histological, immunopathological and immunogenetic features indicates that these patients have a disease identical to sporadic inclusion body myositis.


1995 ◽  
Vol 54 (4) ◽  
pp. 581-587 ◽  
Author(s):  
ANDERS OLDFORS ◽  
ALI-REZA MOSLEMI ◽  
ING-MARIE FYHR ◽  
ELISABETH HOLME ◽  
NILS-GÖRAN LARSSON ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document